<table id="Table1" width="90%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption stylecode="Lrule Rrule Toprule">Table 1.   Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride Tablets</caption>
<col align="left"></col>
<col align="center"></col>
<col align="center"></col>
<col align="center"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule">
<br/>Subject Groups: Metformin Hydrochloride Tablets dose<sup>a</sup>
<br/>(number of subjects)</th>
<th stylecode="Lrule">
<br/>C<sub>max</sub>
<sup>b</sup>
<br/>(µg/mL)</th>
<th stylecode="Lrule">
<br/>T<sub>max</sub>
<sup>c</sup>
<br/>(hrs)</th>
<th stylecode="Lrule Rrule">Renal <br/>Clearance<br/>(mL/min)</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="4">
<paragraph>
<caption>
<sup>a</sup>
</caption> All doses given fasting except the first 18 doses of the multiple dose studies</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph>
<caption>
<sup>b</sup>
</caption> Peak plasma concentration</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph>
<caption>
<sup>c</sup>
</caption> Time to peak plasma concentration</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph>
<caption>
<sup>d</sup>
</caption> Combined results (average means) of five studies: mean age 32 years (range 23-59 years)</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph>
<caption>
<sup>e</sup>
</caption> Kinetic study done following dose 19, given fasting</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph>
<caption>
<sup>f</sup>
</caption> Elderly subjects, mean age 71 years (range 65-81 years)</paragraph>
</td>
</tr>
<tr>
<td colspan="4">
<paragraph>
<caption>
<sup>g</sup>
</caption> CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Healthy, nondiabetic adults:</content>
<br/>   500 mg single dose (24) <br/>   850 mg single dose (74)<sup>d</sup>
<br/>   850 mg three times daily for 19 doses<sup>e</sup> (9)</td>
<td stylecode="Rrule">
<br/>1.03 (±0.33)<br/>1.60 (±0.38)<br/>2.01 (±0.42)</td>
<td stylecode="Rrule">
<br/>2.75 (±0.81)<br/>2.64 (±0.82)<br/>1.79 (±0.94)</td>
<td stylecode="Rrule">
<br/>600 (±132)<br/>552 (±139)<br/>642 (±173)</td>
</tr>
<tr>
<td stylecode="Toprule Rrule Lrule">
<content stylecode="bold">Adults with type 2 diabetes:</content>
<br/>   850 mg single dose (23)<br/>   850 mg three times daily for 19 doses<sup>e</sup> (9)</td>
<td stylecode="Toprule Rrule">
<br/>1.48 (±0.5)<br/>1.90 (±0.62)</td>
<td stylecode="Toprule Rrule">
<br/>3.32 (±1.08)<br/>2.01 (±1.22)</td>
<td stylecode="Toprule Rrule">
<br/>491 (±138)<br/>550 (±160)</td>
</tr>
<tr>
<td stylecode="Toprule Rrule Lrule">
<content stylecode="bold">Elderly<sup>f</sup>, healthy nondiabetic adults:</content>
<br/>   850 mg single dose (12)</td>
<td stylecode="Toprule Rrule">
<br/>2.45 (±0.70)</td>
<td stylecode="Toprule Rrule">
<br/>2.71 (±1.05)</td>
<td stylecode="Toprule Rrule">
<br/>412 (±98)</td>
</tr>
<tr>
<td stylecode="Toprule Rrule Lrule">
<content stylecode="bold">Renal-impaired adults:</content>
<br/>   <content stylecode="bold">850 mg single dose</content>
<br/>    <content stylecode="bold">Mild</content> (CL<sub>cr</sub>
<sup>g</sup> 61-90 mL/min) (5)<br/>    <content stylecode="bold">Moderate</content> (CL<sub>cr</sub> 31-60 mL/min) (4) <br/>    <content stylecode="bold">Severe</content> (CL<sub>cr</sub> 10-30 mL/min) (6)</td>
<td stylecode="Toprule Rrule">
<br/>
<br/>1.86 (±0.52)<br/>4.12 (±1.83)<br/>3.93 (±0.92)</td>
<td stylecode="Toprule Rrule">
<br/>
<br/>3.20 (±0.45)<br/>3.75 (±0.50)<br/>4.01 (±1.10)</td>
<td stylecode="Toprule Rrule">
<br/>
<br/>384 (±122)<br/>108 (±57)<br/>130 (±90)</td>
</tr>
</tbody>
</table>